These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 8615038
41. Development of a suspension packaging cell line for production of high titre, serum-resistant murine leukemia virus vectors. Pizzato M, Merten OW, Blair ED, Takeuchi Y. Gene Ther; 2001 May; 8(10):737-45. PubMed ID: 11420637 [Abstract] [Full Text] [Related]
42. Mutational library analysis of selected amino acids in the receptor binding domain of envelope of Akv murine leukemia virus by conditionally replication competent bicistronic vectors. Bahrami S, Jespersen T, Pedersen FS, Duch M. Gene; 2003 Oct 02; 315():51-61. PubMed ID: 14557064 [Abstract] [Full Text] [Related]
46. Analysis of retroviral packaging lines for generation of replication-competent virus. Muenchau DD, Freeman SM, Cornetta K, Zwiebel JA, Anderson WF. Virology; 1990 May 02; 176(1):262-5. PubMed ID: 2330675 [Abstract] [Full Text] [Related]
47. The potential of retroviral vectors to cotransfer human endogenous retroviruses (HERVs) from human packaging cell lines. Zeilfelder U, Frank O, Sparacio S, Schön U, Bosch V, Seifarth W, Leib-Mösch C. Gene; 2007 Apr 01; 390(1-2):175-9. PubMed ID: 17045761 [Abstract] [Full Text] [Related]
48. A murine leukemia virus (MuLV) long terminal repeat derived from rhesus macaques in the context of a lentivirus vector and MuLV gag sequence results in high-level gene expression in human T lymphocytes. Kung SK, An DS, Chen IS. J Virol; 2000 Apr 01; 74(8):3668-81. PubMed ID: 10729143 [Abstract] [Full Text] [Related]
49. Development of enzyme-linked immunosorbent assay for detecting antibodies to replication-competent murine leukemia virus. Kim S, Park EJ, Yu SS, Kim S. J Virol Methods; 2004 Jun 01; 118(1):1-7. PubMed ID: 15158062 [Abstract] [Full Text] [Related]
50. Amphotropic murine leukemia virus replication in human mammary epithelial cells and the formation of cytomegalovirus-promoter recombinants. Reuss FU, Heber R, Ploss A, Berdel B. Virology; 2001 Dec 05; 291(1):91-100. PubMed ID: 11878879 [Abstract] [Full Text] [Related]
51. A small and efficient dimerization/packaging signal of rat VL30 RNA and its use in murine leukemia virus-VL30-derived vectors for gene transfer. Torrent C, Gabus C, Darlix JL. J Virol; 1994 Feb 05; 68(2):661-7. PubMed ID: 8289369 [Abstract] [Full Text] [Related]
52. Improved safety and titre of murine leukaemia virus (MLV)-based retroviral vectors. Zhao Y, Low W, Collins MK. Gene Ther; 2000 Feb 05; 7(4):300-5. PubMed ID: 10694810 [Abstract] [Full Text] [Related]
53. Rapid establishment of stable retroviral packaging cells and recombinant susceptible target cell lines employing novel transposon vectors derived from Sleeping Beauty. Berg K, Schäfer VN, Bartnicki N, Eggenschwiler R, Cantz T, Stitz J. Virology; 2019 May 05; 531():40-47. PubMed ID: 30852270 [Abstract] [Full Text] [Related]
54. Tissue-specific transcriptional targeting of a replication-competent retroviral vector. Logg CR, Logg A, Matusik RJ, Bochner BH, Kasahara N. J Virol; 2002 Dec 05; 76(24):12783-91. PubMed ID: 12438603 [Abstract] [Full Text] [Related]
55. New retrovirus helper cells with almost no nucleotide sequence homology to retrovirus vectors. Dougherty JP, Wisniewski R, Yang SL, Rhode BW, Temin HM. J Virol; 1989 Jul 05; 63(7):3209-12. PubMed ID: 2524600 [Abstract] [Full Text] [Related]
56. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Danos O, Mulligan RC. Proc Natl Acad Sci U S A; 1988 Sep 05; 85(17):6460-4. PubMed ID: 3413107 [Abstract] [Full Text] [Related]
58. A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors. Cockrell AS, Ma H, Fu K, McCown TJ, Kafri T. Mol Ther; 2006 Aug 05; 14(2):276-84. PubMed ID: 16516556 [Abstract] [Full Text] [Related]
60. Development of methods for somatic cell gene therapy directed against viral diseases, using retroviral vectors carrying the murine or human interferon-beta coding sequence: establishment of the antiviral state in human cells. Lauret E, Riviere I, Rousseau V, Vieillard V, De Maeyer-Guignard J, De Maeyer E. Hum Gene Ther; 1993 Oct 05; 4(5):567-77. PubMed ID: 8280795 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]